Antisense Oligonucleotide Eluforsen Is Safe and Improves Respiratory Symptoms in F508DEL Cystic Fibrosis

Journal of Cystic Fibrosis - Netherlands
doi 10.1016/j.jcf.2019.05.014
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Cystic Fibrosis F508del Mutation in Crohn's Disease

Journal of Cystic Fibrosis
Child HealthPulmonaryPediatricsPerinatologyRespiratory Medicine
2011English

Changes in the Parent Cystic Fibrosis Questionnaire-Revised (CFQ-R) With Respiratory Symptoms in Preschool Children With Cystic Fibrosis

Journal of Cystic Fibrosis
Child HealthPulmonaryPediatricsPerinatologyRespiratory Medicine
2020English

GP274 Liver Tests in F508del Homozygous Cystic Fibrosis Patients on Orkambi

2019English

Thymosin Α-1 Does Not Correct F508del-CFTR in Cystic Fibrosis Airway Epithelia

JCI insight
Medicine
2018English

Thymosin Α-1 Does Not Correct F508del-CFTR in Cystic Fibrosis Airway Epithelia

JCI insight
Medicine
2019English

Early Respiratory Infection Is Associated With Reduced Spirometry in Children With Cystic Fibrosis

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2014English

Doxycycline Improves Clinical Outcomes During Cystic Fibrosis Exacerbations

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2017English

Early Respiratory Viral Infections in Infants With Cystic Fibrosis

Journal of Cystic Fibrosis
Child HealthPulmonaryPediatricsPerinatologyRespiratory Medicine
2019English

Is Cystic Fibrosis Mucus Abnormal?

Pediatric Research
Child HealthPediatricsPerinatology
1981English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy